Emzor Pharmaceutical Industries Limited Launches ₦10 Billion Series 2 Commercial Paper
AssetBase is pleased to announce that Emzor Pharmaceutical Industries Limited (“Emzor” or “the Company”) has launched its ₦10.0 billion Series 2 Commercial Paper (CP) under its ₦10.0 billion Commercial Paper Programme. This offering is now available to retail investors via the AssetBase platform, providing a unique opportunity to